PET Imaging of Oncogene Overexpression Using 64Cu-Vasoactive Intestinal Peptide (VIP) Analog: Comparison with 99mTc-VIP Analog
Mathew L. Thakur, PhD1,2,
Mohan R. Aruva, PhD1,2,
Jean Gariepy, MD3,
Paul Acton, PhD4,
Satish Rattan, MD5,
Shyam Prasad, PhD1,2,
Eric Wickstrom, PhD2,6 and
Abass Alavi, MD4
1 Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania
2 Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania
3 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
4 Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
5 Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
6 Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, Pennsylvania

View larger version (14K):
[in a new window]
|
FIGURE 1. Schematic presentation of TP3982.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 3. SELDI-TOF-mass spectrum of Cu-TP3982 complex, depicting the complex mass of 4,049.7 Da and the mass of unreacted TP3982 at 3,982.7 Da.
|
|

View larger version (17K):
[in a new window]
|
FIGURE 4. HPLC elution profile of 64Cu-TP3982. 100% radioactivity was eluted in a single peak at Rt 8 min. Unbound 64Cu elutes at Rt 4.2 min. The diagonal line is percent solvent B (B = 0.1% TFA/ACN; A = 0.1% TFA/H2O).
|
|
Copyright © 2004 by the Society of Nuclear Medicine.